(Q38971331)

8 September 2017

In vivo quantitative phosphoproteomic profiling identifies novel regulators of castration-resistant prostate cancer growth (English)

1 reference

8 September 2017

1 reference

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25065596%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Diego Iglesias-Gato

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25065596%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Amilcar Flores-Morales

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25065596%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

author name string

N Jiang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25065596%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

K Hjorth-Jensen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25065596%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

O Hekmat

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25065596%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

T Kruse

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25065596%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

C Wang

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25065596%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

W Wei

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25065596%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

B Ke

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25065596%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

B Yan

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25065596%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Y Niu

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25065596%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

language of work or name

English

0 references

publication date

28 July 2014

1 reference

8 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25065596%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

volume

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25065596%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

issue

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25065596%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

page(s)

2764-2776

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25065596%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/onc.2014.206

31 May 2020

exact match

0 references

cites work

Screening and prostate-cancer mortality in a randomized European study

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.206

Understanding the epidemiology, natural history, and key pathways involved in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.206

Integrative genomic profiling of human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.206

The mutational landscape of lethal castration-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.206

In vivo amplification of the androgen receptor gene and progression of human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.206

Chromosomal aberrations in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.206

Cell autonomous role of PTEN in regulating castration-resistant prostate cancer growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.206

Reciprocal feedback regulation of PI3K and androgen receptor signaling in PTEN-deficient prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.206

PTEN deficiency is fully penetrant for prostate adenocarcinoma in C57BL/6 mice via mTOR-dependent growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.206

Prolonging hormone sensitivity in prostate cancer xenografts through dual inhibition of AR and mTOR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.206

Phase II trial of RAD001 and bicalutamide for castration-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.206

Inhibition of tumor growth progression by antiandrogens and mTOR inhibitor in a Pten-deficient mouse model of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.206

Global, in vivo, and site-specific phosphorylation dynamics in signaling networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.206

Global effects of kinase inhibitors on signaling networks revealed by quantitative phosphoproteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.206

Androgen receptor is a tumor suppressor and proliferator in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.206

Super-SILAC mix for quantitative proteomics of human tumor tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.206

Structure of the coding sequence and primary amino acid sequence of acetyl-coenzyme A carboxylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.206

Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.206

mTOR: from growth signal integration to cancer, diabetes and ageing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.206

PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.206

The Hippo pathway and human cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.206

21 January 2018

PAK signaling in cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.206

AKT/PKB signaling: navigating downstream

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.206

Identification of S664 TSC2 phosphorylation as a marker for extracellular signal-regulated kinase mediated mTOR activation in tuberous sclerosis and human cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.206

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.206

Cytoscape: a software environment for integrated models of biomolecular interaction networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.206

Enrichment map: a network-based method for gene-set enrichment visualization and interpretation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.206

Upregulation of MAPK pathway is associated with survival in castrate-resistant prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.206

Metastatic castration-resistant prostate cancer reveals intrapatient similarity and interpatient heterogeneity of therapeutic kinase targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.206

Androgen-induced programs for prostate epithelial growth and invasion arise in embryogenesis and are reactivated in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.206

Aberrant Rheb-mediated mTORC1 activation and Pten haploinsufficiency are cooperative oncogenic events

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.206

MYC activity mitigates response to rapamycin in prostate cancer through eukaryotic initiation factor 4E-binding protein 1-mediated inhibition of autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.206

Bone metastatic LNCaP-derivative C4-2B prostate cancer cell line mineralizes in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.206

Small-molecule p21-activated kinase inhibitor PF-3758309 is a potent inhibitor of oncogenic signaling and tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.206

An isoform-selective, small-molecule inhibitor targets the autoregulatory mechanism of p21-activated kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.206

Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.206

mTOR signaling in growth control and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.206

Longitudinal analysis of androgen deprivation of prostate cancer cells identifies pathways to androgen independence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.206

Cell detachment activates the Hippo pathway via cytoskeleton reorganization to induce anoikis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.206

Integrative molecular concept modeling of prostate cancer progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.206

Ajuba LIM proteins are negative regulators of the Hippo signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.206

Quantitative maps of protein phosphorylation sites across 14 different rat organs and tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.206

MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.206

Andromeda: a peptide search engine integrated into the MaxQuant environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.206

Status of large-scale analysis of post-translational modifications by mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.206

TIMP-1 Increases Expression and Phosphorylation of Proteins Associated with Drug Resistance in Breast Cancer Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.206

A dual pressure linear ion trap Orbitrap instrument with very high sequencing speed.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.206

The Ndc80 internal loop is required for recruitment of the Ska complex to establish end-on microtubule attachment to kinetochores

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.206

Ezrin mediates c-Myc actions in prostate cancer cell invasion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.206

Clinical significance of alterations of chromosome 8 in high-grade, advanced, nonmetastatic prostate carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.206

Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.206

High cell proliferation activity determined by DNA flow cytometry predicts poor prognosis after relapse in prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.206

The coming age of complete, accurate, and ubiquitous proteomes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.206

Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25065596

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

LNCaP model of human prostatic carcinoma.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25065596

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/ONC.2014.206

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25065596%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

31 May 2020

1032687941

0 references

Fatcat ID

release_th77uyfcvnbcrpsaffff4kjcha

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/th77uyfcvnbcrpsaffff4kjcha

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25065596%20AND%20SRC:MED&resulttype=core&format=json